Evidence for Wnt5A crosstalk with TGFβ1 was shown in mammary gland development and breast cancer, given that Wnt5A was required for TGF-β acting through antagonizing β-catenin, thereby limiting mammary gland morphogenesis [15]. Here, WNT5A is linked to breast carcinoma.